The National Bleeding Disorders Foundation (NBDF) will be leading efforts this March — during Bleeding Disorders Awareness Month, simply called BDAM — to provide…
Thrombotic thrombocytopenic purpura
Thrombotic thrombocytopenic purpura is a rare, life-threatening blood disorder marked by dangerous clotting and low platelet counts. Prompt diagnosis and treatment are critical, and with proper care, most people recover and avoid serious complications.
While there’s no cure for immune thrombocytopenia, a range of treatments — from steroids to platelet-boosting therapies — can help manage symptoms. Choosing the right plan depends on platelet levels, bleeding risk, and individual health considerations.
Latest news
Researchers are developing a potential treatment for immune-mediated thrombotic thrombocytopenic purpura (iTTP) that promotes immune tolerance rather than immunosuppression, according to a study. The…